Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung - PubMed (original) (raw)
Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung
R B Devlin et al. Am J Respir Cell Mol Biol. 1991 Jan.
Abstract
An acute (2 h) exposure of humans to 0.4 ppm ozone initiates biochemical changes in the lung that result in the production of components mediating inflammation and acute lung damage as well as components having the potential to lead to long-term effects such as fibrosis. However, many people are exposed to lower levels of ozone than this, but for periods of several hours. Therefore, it is important to determine if a prolonged exposure to low levels of ozone is also capable of causing cellular and biochemical changes in the lung. Nonsmoking males were randomly exposed to filtered air and either 0.10 ppm ozone or 0.08 ppm ozone for 6.6 h with moderate exercise (40 liters/min). Bronchoalveolar lavage (BAL) was performed 18 h after each exposure, and cells and fluid were analyzed. The BAL fluid of volunteers exposed to 0.10 ppm ozone had significant increases in neutrophils (PMNs), protein, prostaglandin E2 (PGE2), fibronectin, interleukin-6 (IL-6), and lactate dehydrogenase (LDH) compared with BAL fluid from the same volunteers exposed to filtered air. In addition, there was a decrease in the ability of alveolar macrophages to phagocytize yeast via the complement receptor. Exposure to 0.08 ppm ozone resulted in significant increases in PMNs, PGE2, LDH, IL-6, alpha 1-antitrypsin, and decreased phagocytosis via the complement receptor. However, BAL fluid protein and fibronectin were no longer significantly elevated. We conclude that exposure of humans to as low a level as 0.08 ppm for 6.6 h is sufficient to initiate an inflammatory reaction in the lung.
Similar articles
- Time-dependent changes of inflammatory mediators in the lungs of humans exposed to 0.4 ppm ozone for 2 hr: a comparison of mediators found in bronchoalveolar lavage fluid 1 and 18 hr after exposure.
Devlin RB, McDonnell WF, Becker S, Madden MC, McGee MP, Perez R, Hatch G, House DE, Koren HS. Devlin RB, et al. Toxicol Appl Pharmacol. 1996 May;138(1):176-85. doi: 10.1006/taap.1996.0111. Toxicol Appl Pharmacol. 1996. PMID: 8658507 - Effects of ozone on normal and potentially sensitive human subjects. Part II: Airway inflammation and responsiveness to ozone in nonsmokers and smokers.
Frampton MW, Morrow PE, Torres A, Voter KZ, Whitin JC, Cox C, Speers DM, Tsai Y, Utell MJ. Frampton MW, et al. Res Rep Health Eff Inst. 1997 Jun;(78):39-72; discussion 81-99. Res Rep Health Eff Inst. 1997. PMID: 9387196 Clinical Trial. - Mechanisms of response to ozone exposure: the role of mast cells in mice.
Kleeberger SR, Longphre M, Tankersley CG. Kleeberger SR, et al. Res Rep Health Eff Inst. 1999 Apr;(85):1-30; discussion 31-6. Res Rep Health Eff Inst. 1999. PMID: 10349676 - Greater ozone-induced inflammatory responses in subjects with asthma.
Scannell C, Chen L, Aris RM, Tager I, Christian D, Ferrando R, Welch B, Kelly T, Balmes JR. Scannell C, et al. Am J Respir Crit Care Med. 1996 Jul;154(1):24-9. doi: 10.1164/ajrccm.154.1.8680687. Am J Respir Crit Care Med. 1996. PMID: 8680687 - [Evaluation of pulmonary toxicity of heavy metal compounds].
Hirano S. Hirano S. Nihon Eiseigaku Zasshi. 1996 Feb;50(6):1013-25. doi: 10.1265/jjh.50.1013. Nihon Eiseigaku Zasshi. 1996. PMID: 8720928 Review. Japanese.
Cited by
- Inflammatory and repair pathways induced in human bronchoalveolar lavage cells with ozone inhalation.
Leroy P, Tham A, Wong H, Tenney R, Chen C, Stiner R, Balmes JR, Paquet AC, Arjomandi M. Leroy P, et al. PLoS One. 2015 Jun 2;10(6):e0127283. doi: 10.1371/journal.pone.0127283. eCollection 2015. PLoS One. 2015. PMID: 26035830 Free PMC article. - Baseline repeated measures from controlled human exposure studies: associations between ambient air pollution exposure and the systemic inflammatory biomarkers IL-6 and fibrinogen.
Thompson AM, Zanobetti A, Silverman F, Schwartz J, Coull B, Urch B, Speck M, Brook JR, Manno M, Gold DR. Thompson AM, et al. Environ Health Perspect. 2010 Jan;118(1):120-4. doi: 10.1289/ehp.0900550. Environ Health Perspect. 2010. PMID: 20056584 Free PMC article. - Ozone as u-shaped dose responses molecules (hormetins).
Martínez-Sánchez G, Pérez-Davison G, Re L, Giuliani A. Martínez-Sánchez G, et al. Dose Response. 2010 May 10;9(1):32-49. doi: 10.2203/dose-response.10-001.Martinez-Sanchez. Dose Response. 2010. PMID: 21431076 Free PMC article. Retracted. - Tropospheric ozone: respiratory effects and Australian air quality goals.
Woodward A, Guest C, Steer K, Harman A, Scicchitano R, Pisaniello D, Calder I, McMichael A. Woodward A, et al. J Epidemiol Community Health. 1995 Aug;49(4):401-7. doi: 10.1136/jech.49.4.401. J Epidemiol Community Health. 1995. PMID: 7650464 Free PMC article. Review. - Introduction to working group on tropospheric ozone, Health Effects Institute environmental epidemiology planning project.
Tager IB. Tager IB. Environ Health Perspect. 1993 Dec;101 Suppl 4(Suppl 4):205-7. doi: 10.1289/ehp.93101s4205. Environ Health Perspect. 1993. PMID: 8206032 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical